Literature DB >> 10487452

Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis.

G Mujtaba1, M Khalid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10487452     DOI： 10.1046/j.1365-4362.1999.00769.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  8 in total

Review 1.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

2.  Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.

Authors:  Yavuz Yesilova; Hacer Altın Surucu; Nurittin Ardic; Mustafa Aksoy; Abdullah Yesilova; Steve Oghumu; Abhay R Satoskar
Journal:  J Dermatolog Treat       Date:  2015-06-24       Impact factor: 3.359

Review 3.  [Uncommon clinical manifestations of cutaneous leishmaniasis].

Authors:  K Hayani; A Dandashli; E Weisshaar
Journal:  Hautarzt       Date:  2014-10       Impact factor: 0.751

Review 4.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

5.  Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial.

Authors:  Alireza Khatami; Rezvan Talaee; Makan Rahshenas; Ali Khamesipour; Pedram Mehryan; Sepideh Tehrani; Yahya Dowlati; Alireza Firooz
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial.

Authors:  Saeedeh Farajzadeh; Iraj Esfandiarpour; Ali Akbar Haghdoost; Saman Mohammadi; Azadeh Mohebbi; Elham Mohebbi; Mahshid Mostafavi
Journal:  Iran J Parasitol       Date:  2015 Jan-Mar       Impact factor: 1.012

7.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

8.  Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial.

Authors:  Amir Javadi; Ali Khamesipour; Mohammad Ghoorchi; Mahdieh Bahrami; Alireza Khatami; Iraj Sharifi; Seyed Ebrahim Eskandari; Alireza Fekri; Mohamad Reza Aflatoonian; Alireza Firooz
Journal:  PLoS Negl Trop Dis       Date:  2022-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.